Related references
Note: Only part of the references are listed.A Randomized, Controlled, Observer-Blinded Phase 1 Study of the Safety and Immunogenicity of a Respiratory Syncytial Virus Vaccine With or Without Alum Adjuvant
Joanne M. Langley et al.
JOURNAL OF INFECTIOUS DISEASES (2017)
A Randomized, Blinded, Controlled, Dose-Ranging Study of a Respiratory Syncytial Virus Recombinant Fusion (F) Nanoparticle Vaccine in Healthy Women of Childbearing Age
Gregory M. Glenn et al.
JOURNAL OF INFECTIOUS DISEASES (2016)
Influence of antigen conformation and mode of presentation on the antibody and protective responses against human respiratory syncytial virus: relevance for vaccine development
Jose A. Melero
EXPERT REVIEW OF VACCINES (2016)
Vaccination against respiratory syncytial virus in pregnancy: a suitable tool to combat global infant morbidity and mortality?
Anja Saso et al.
LANCET INFECTIOUS DISEASES (2016)
Experimental animal model for analyzing immunobiological responses following vaccination with formalin-inactivated respiratory syncytial virus
Akihito Sawada et al.
MICROBIOLOGY AND IMMUNOLOGY (2016)
Iterative structure-based improvement of a fusion-glycoprotein vaccine against RSV
M. Gordon Joyce et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2016)
A phase 1a, first-in-human, randomized study of a respiratory syncytial virus F protein vaccine with and without a toll-like receptor-4 agonist and stable emulsion adjuvant
Judith Falloon et al.
VACCINE (2016)
Iterative structure-based improvement of a fusion-glycoprotein vaccine against RSV
M. Gordon Joyce et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2016)
Systematic review and meta-analysis of the effectiveness of commercially available vaccines against bovine herpesvirus, bovine viral diarrhea virus, bovine respiratory syncytial virus, and parainfluenza type 3 virus for mitigation of bovine respiratory disease complex in cattle
Miles E. Theurer et al.
JAVMA-JOURNAL OF THE AMERICAN VETERINARY MEDICAL ASSOCIATION (2015)
Single-Chain Soluble BG505.SOSIP gp140 Trimers as Structural and Antigenic Mimics of Mature Closed HIV-1 Env
Ivelin S. Georgiev et al.
JOURNAL OF VIROLOGY (2015)
Prefusion F-specific antibodies determine the magnitude of RSV neutralizing activity in human sera
Joan O. Ngwuta et al.
SCIENCE TRANSLATIONAL MEDICINE (2015)
Efficacy of a virus-vectored vaccine against human and bovine respiratory syncytial virus infections
Geraldine Taylor et al.
SCIENCE TRANSLATIONAL MEDICINE (2015)
A highly stable prefusion RSV F vaccine derived from structural analysis of the fusion mechanism
Anders Krarup et al.
NATURE COMMUNICATIONS (2015)
Cleavage-Independent HIV-1 Env Trimers Engineered as Soluble Native Spike Mimetics for Vaccine Design
Shailendra Kumar Sharma et al.
CELL REPORTS (2015)
Characterization of a Prefusion-Specific Antibody That Recognizes a Quaternary, Cleavage-Dependent Epitope on the RSV Fusion Glycoprotein
Morgan S. A. Gilman et al.
PLOS PATHOGENS (2015)
Vaccine Safety and Efficacy Evaluation of a Recombinant Bovine Respiratory Syncytial Virus (BRSV) with Deletion of the SH Gene and Subunit Vaccines Based On Recombinant Human RSV Proteins: N-nanorings, P and M2-1, in Calves with Maternal Antibodies
Krister Blodorn et al.
PLOS ONE (2014)
Specificity and Effector Functions of Human RSV-Specific IgG from Bovine Milk
Gerco den Hartog et al.
PLOS ONE (2014)
Respiratory Syncytial Virus Infection in Cattle
R. E. Sacco et al.
VETERINARY PATHOLOGY (2014)
Respiratory Syncytial Virus-A Comprehensive Review
Andrea T. Borchers et al.
CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY (2013)
Cross-neutralization of four paramyxoviruses by a human monoclonal antibody
Davide Corti et al.
NATURE (2013)
Structure of RSV Fusion Glycoprotein Trimer Bound to a Prefusion-Specific Neutralizing Antibody
Jason S. McLellan et al.
SCIENCE (2013)
Structure-Based Design of a Fusion Glycoprotein Vaccine for Respiratory Syncytial Virus
Jason S. McLellan et al.
SCIENCE (2013)
Strategic priorities for respiratory syncytial virus (RSV) vaccine development
L. J. Anderson et al.
VACCINE (2013)
Neutralizing antibodies against the preactive form of respiratory syncytial virus fusion protein offer unique possibilities for clinical intervention
Margarita Magro et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Biological challenges and technological opportunities for respiratory syncytial virus vaccine development
Barney S. Graham
IMMUNOLOGICAL REVIEWS (2011)
Structure of Respiratory Syncytial Virus Fusion Glycoprotein in the Postfusion Conformation Reveals Preservation of Neutralizing Epitopes
Jason S. McLellan et al.
JOURNAL OF VIROLOGY (2011)
Structural basis for immunization with postfusion respiratory syncytial virus fusion F glycoprotein (RSV F) to elicit high neutralizing antibody titers
Kurt A. Swanson et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Features and development of Coot
P. Emsley et al.
ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY (2010)
PHENIX: a comprehensive Python-based system for macromolecular structure solution
Paul D. Adams et al.
ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY (2010)
Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-analysis
Harish Nair et al.
LANCET (2010)
Structural basis of respiratory syncytial virus neutralization by motavizumab
Jason S. McLellan et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2010)
Lack of antibody affinity maturation due to poor Toll-like receptor stimulation leads to enhanced respiratory syncytial virus disease
Maria Florencia Delgado et al.
NATURE MEDICINE (2009)
Phaser crystallographic software
Airlie J. McCoy et al.
JOURNAL OF APPLIED CRYSTALLOGRAPHY (2007)
Development of motavizumab, an ultra-potent antibody for the prevention of respiratory syncytial virus infection in the upper and lower respiratory tract
Herren Wu et al.
JOURNAL OF MOLECULAR BIOLOGY (2007)
Bovine respiratory syncytial virus infection
Jean-Francois Valarcher et al.
VETERINARY RESEARCH (2007)
EMAN2: An extensible image processing suite for electron microscopy
Guang Tang et al.
JOURNAL OF STRUCTURAL BIOLOGY (2007)
Respiratory syncytial virus infection in elderly and high-risk adults
AR Falsey et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Vaccine-induced immunopathology during bovine respiratory syncytial virus infection: Exploring the parameters of pathogenesis
AFG Antonis et al.
JOURNAL OF VIROLOGY (2003)
Role of alpha/beta interferons in the attenuation and immunogenicity of recombinant bovine respiratory syncytial viruses lacking NS proteins
JF Valarcher et al.
JOURNAL OF VIROLOGY (2003)
High mortality rate associated with bovine respiratory syncytial virus (BRSV) infection in Belgian White Blue calves previously vaccinated with an inactivated BRSV vaccine
P Schreiber et al.
JOURNAL OF VETERINARY MEDICINE SERIES B-INFECTIOUS DISEASES AND VETERINARY PUBLIC HEALTH (2000)
Share Paper
